Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression.

Saved in:
Bibliographic Details
Title: Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression.
Authors: Pechtimaldjian L; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France., Jullié ML; Service de Pathologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux F-33000, France., Rousson C; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France., Laanani F; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France., Clachet J; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France., Idrissi Y; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France., Loot M; Service de Chirurgie Pédiatrique, Centre Hospitalier Universitaire de Bordeaux, Bordeaux F-33000, France., Cario-Andre M; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.; Centre de Référence Maladies Rares de la Peau et des Muqueuses d'origine Génétique Sud, Bordeaux F-33000, France.; Aquiderm, Bordeaux F-33000, France., Prey S; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.; Centre de Référence Maladies Rares de la Peau et des Muqueuses d'origine Génétique Sud, Bordeaux F-33000, France.; Service de dermatologie pédiatrique et adulte, Centre Hospitalier Universitaire de Bordeaux, Bordeaux F-33000, France., Taieb A; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France., Leauté-Labrèze C; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.; Centre de Référence Maladies Rares de la Peau et des Muqueuses d'origine Génétique Sud, Bordeaux F-33000, France.; Service de dermatologie pédiatrique et adulte, Centre Hospitalier Universitaire de Bordeaux, Bordeaux F-33000, France., Mathivet T; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France., Moisan F; University of Bordeaux, Inserm, Bordeaux Institute of Oncology, UMR 1312, Bordeaux F-33076, France.
Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2026 Jun 16; Vol. 123 (24), pp. e2526271123. Date of Electronic Publication: 2026 Jun 10.
Publication Type: Journal Article
Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1091-6490
DOI:10.1073/pnas.2526271123